Not Yet Recruiting PHASE3 INTERVENTIONAL 2-arm
NCT07084519
Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction
Randomized Controlled Trial of Postmastectomy Hypofractionated Radiotherapy Versus Conventional Fractionated Radiotherapy in Breast Cancer Patients Undergoing Prosthetic Breast Reconstruction
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions
Breast Cancer Breast Reconstruction Radiation Oncology
Updated 1 time since 2025 Last updated: Jul 22, 2025 Started: Aug 10, 2025 Primary completion: Dec 31, 2025 Completion: Dec 31, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE3 clinical study on Breast Cancer and Breast Reconstruction, this trial is actively recruiting participants. The trial is conducted by Cancer Institute and Hospital, Chinese Academy of Medical Sciences and has accumulated 1 data snapshot since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Data source: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .